Innoviva Company Insiders
INVA Stock | USD 17.41 0.14 0.80% |
Innoviva's insiders are aggressively buying. The analysis of insiders' sentiment of trading Innoviva stock suggests that vertually all insiders are extremely bullish at this time. Innoviva employs about 112 people. The company is managed by 4 executives with a total tenure of roughly 262 years, averaging almost 65.0 years of service per executive, having 28.0 employees per reported executive.
Innoviva's Insider Buying Vs Selling
100
Selling | Buying |
Latest Trades
2023-06-05 | Alexander J Denner | Acquired 7000 @ 13.04 | View | ||
2023-05-30 | Alexander J Denner | Acquired 120000 @ 13.01 | View | ||
2023-05-25 | Alexander J Denner | Acquired 50000 @ 13.09 | View | ||
2023-05-17 | Alexander J Denner | Acquired 50000 @ 13.07 | View | ||
2023-05-11 | Alexander J Denner | Acquired 290000 @ 12.34 | View | ||
2023-03-10 | Pavel Raifeld | Acquired 3000 @ 10.87 | View | ||
2022-03-31 | Innoviva, Inc. | Acquired 5385208 @ 5 | View | ||
2022-02-09 | Innoviva, Inc. | Acquired 3614792 @ 5 | View |
Monitoring Innoviva's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Innoviva |
Innoviva's Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Innoviva's future performance. Based on our forecasts, it is anticipated that Innoviva will maintain a workforce of about 250 employees by January 2025.Innoviva Management Team Effectiveness
The company has return on total asset (ROA) of 0.0937 % which means that it generated a profit of $0.0937 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0997 %, meaning that it created $0.0997 on every $100 dollars invested by stockholders. Innoviva's management efficiency ratios could be used to measure how well Innoviva manages its routine affairs as well as how well it operates its assets and liabilities. At present, Innoviva's Return On Tangible Assets are projected to increase slightly based on the last few years of reporting. The current year's Return On Capital Employed is expected to grow to 0.15, whereas Return On Equity is forecasted to decline to 0.26. At present, Innoviva's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Current Assets Total is expected to grow to about 944.3 M, whereas Other Assets are forecasted to decline to about 131.6 M.The current year's Net Income Applicable To Common Shares is expected to grow to about 258.3 M, whereas Common Stock Shares Outstanding is forecasted to decline to about 81.9 M.
Innoviva Workforce Comparison
Innoviva is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 1,154. Innoviva holds roughly 112 in number of employees claiming about 10% of equities under Health Care industry.
The company has Profit Margin (PM) of 0.18 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.48 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.48. Innoviva Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Innoviva insiders, such as employees or executives, is commonly permitted as long as it does not rely on Innoviva's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Innoviva insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
---|---|---|---|---|---|
2024-12-01 | 1.0 | 1 | 1 | 300.00 | 976.00 |
2024-06-01 | 3.0 | 12 | 4 | 143,538 | 3,283 |
2024-03-01 | 1.4286 | 10 | 7 | 496,875 | 55,841 |
2023-12-01 | 0.3333 | 1 | 3 | 302.00 | 11,778 |
2023-09-01 | 2.0 | 2 | 1 | 210,000 | 785.00 |
2023-06-01 | 27.0 | 27 | 1 | 917,890 | 784.00 |
2023-03-01 | 0.5 | 1 | 2 | 3,000 | 4,352 |
2022-12-01 | 1.0 | 1 | 1 | 433.00 | 828.00 |
2022-06-01 | 9.0 | 9 | 1 | 229,775 | 828.00 |
2022-03-01 | 1.0 | 1 | 1 | 6,691 | 2,277 |
2021-09-01 | 0.3333 | 1 | 3 | 1,129 | 4,691 |
2021-06-01 | 3.0 | 9 | 3 | 224,892 | 32,256,019 |
2021-03-01 | 2.0 | 4 | 2 | 27,665 | 2,108 |
2020-06-01 | 2.5 | 5 | 2 | 84,585 | 1,205 |
2020-03-01 | 0.6667 | 2 | 3 | 24,475 | 6,576 |
2019-09-01 | 1.0 | 1 | 1 | 3,000 | 600.00 |
2019-06-01 | 5.0 | 5 | 1 | 81,995 | 601.00 |
2019-03-01 | 2.0 | 6 | 3 | 63,831 | 10,063 |
2018-09-01 | 0.1667 | 1 | 6 | 1,779 | 25,809 |
2018-06-01 | 1.2 | 6 | 5 | 85,494 | 29,480 |
2018-03-01 | 0.8571 | 6 | 7 | 273,495 | 80,344 |
2017-12-01 | 0.1667 | 2 | 12 | 29,026 | 117,286 |
2017-06-01 | 0.8571 | 6 | 7 | 119,142 | 34,739 |
2017-03-01 | 0.8333 | 5 | 6 | 813,727 | 47,440 |
2016-12-01 | 0.3333 | 4 | 12 | 197,152 | 37,006 |
2016-06-01 | 0.8 | 4 | 5 | 73,312 | 14,825 |
2016-03-01 | 1.25 | 5 | 4 | 657,368 | 35,978 |
2015-06-01 | 1.2 | 6 | 5 | 157,692 | 63,018 |
2015-03-01 | 3.0 | 6 | 2 | 519,989 | 13,578 |
2014-09-01 | 0.7143 | 5 | 7 | 408,890 | 137,450 |
2014-06-01 | 7.1429 | 50 | 7 | 1,506,509 | 176,601 |
2014-03-01 | 0.4286 | 9 | 21 | 253,150 | 318,388 |
2013-12-01 | 0.25 | 1 | 4 | 130,473 | 23,753 |
2013-09-01 | 1.0 | 7 | 7 | 3,114,157 | 70,305 |
2013-06-01 | 0.88 | 22 | 25 | 885,215 | 1,152,206 |
2013-03-01 | 1.5 | 9 | 6 | 167,037 | 33,732 |
2012-12-01 | 1.0 | 8 | 8 | 321,509 | 25,423 |
2012-09-01 | 0.2941 | 5 | 17 | 487,212 | 438,765 |
2012-06-01 | 1.875 | 15 | 8 | 10,135,225 | 112,558 |
2012-03-01 | 1.75 | 7 | 4 | 124,468 | 46,343 |
2011-12-01 | 0.3333 | 3 | 9 | 88,616 | 65,430 |
2011-09-01 | 0.5 | 3 | 6 | 9,507,190 | 9,413,513 |
2011-06-01 | 1.4375 | 23 | 16 | 480,580 | 429,906 |
2011-03-01 | 0.6857 | 24 | 35 | 1,652,904 | 1,537,114 |
2010-12-01 | 1.5455 | 17 | 11 | 5,950,446 | 135,517 |
2010-09-01 | 0.125 | 1 | 8 | 6,451 | 22,547 |
2010-06-01 | 1.7 | 17 | 10 | 158,708 | 145,455 |
2010-03-01 | 1.2857 | 9 | 7 | 224,960 | 40,545 |
2009-12-01 | 0.125 | 1 | 8 | 200,000 | 209,591 |
2009-09-01 | 0.1111 | 1 | 9 | 9,000 | 29,425 |
2009-06-01 | 3.0 | 15 | 5 | 109,000 | 6,753 |
2009-03-01 | 1.0 | 5 | 5 | 226,000 | 7,700 |
2008-09-01 | 2.0 | 2 | 1 | 90,000 | 34,676 |
2008-06-01 | 0.6316 | 12 | 19 | 90,898 | 39,800 |
2007-12-01 | 0.15 | 3 | 20 | 54,310 | 83,749 |
2007-09-01 | 0.0706 | 6 | 85 | 265,834 | 57,560 |
2007-06-01 | 1.5 | 15 | 10 | 429,435 | 54,598 |
2006-06-01 | 0.2048 | 17 | 83 | 297,234 | 101,187 |
2005-12-01 | 3.5 | 7 | 2 | 28,316 | 33,840 |
2005-09-01 | 1.0 | 4 | 4 | 59,000 | 59,000 |
Innoviva Notable Stakeholders
An Innoviva stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Innoviva often face trade-offs trying to please all of them. Innoviva's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Innoviva's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Pavel CFA | Chief Officer | Profile | |
Patricia Drake | I Therapeutics | Profile | |
Marianne CPA | Chief Secretary | Profile | |
Stephen MBA | Chief Officer | Profile |
About Innoviva Management Performance
The success or failure of an entity such as Innoviva often depends on how effective the management is. Innoviva management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Innoviva management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Innoviva management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | 0.18 | 0.19 | |
Return On Capital Employed | 0.15 | 0.15 | |
Return On Assets | 0.14 | 0.15 | |
Return On Equity | 0.27 | 0.26 |
Please note, the presentation of Innoviva's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Innoviva's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Innoviva's management manipulating its earnings.
Innoviva Workforce Analysis
Traditionally, organizations such as Innoviva use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Innoviva within its industry.Innoviva Manpower Efficiency
Return on Innoviva Manpower
Revenue Per Employee | 2.8M | |
Revenue Per Executive | 77.6M | |
Net Income Per Employee | 1.6M | |
Net Income Per Executive | 44.9M | |
Working Capital Per Employee | 2.7M | |
Working Capital Per Executive | 76.5M |
Complementary Tools for Innoviva Stock analysis
When running Innoviva's price analysis, check to measure Innoviva's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innoviva is operating at the current time. Most of Innoviva's value examination focuses on studying past and present price action to predict the probability of Innoviva's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innoviva's price. Additionally, you may evaluate how the addition of Innoviva to your portfolios can decrease your overall portfolio volatility.
CEOs Directory Screen CEOs from public companies around the world | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |